Kortüm KM - Search Results

1

Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease.

Zhou X, Flüchter P, Nickel K, Meckel K, Messerschmidt J, Böckle D, Knorz S, Steinhardt MJ, Krummenast F, Danhof S, Einsele H, Kortüm KM, Rasche L. Zhou X, et al. Among authors: kortum km. Cancers (Basel). 2020 Apr 23;12(4):1035. doi: 10.3390/cancers12041035. Cancers (Basel). 2020. PMID: 32340174 Free PMC article.

2

[Multiple myeloma].

Kortüm KM, Engelhardt M, Rasche L, Knop S, Einsele H. Kortüm KM, et al. Internist (Berl). 2013 Aug;54(8):963-77. doi: 10.1007/s00108-013-3336-2. Internist (Berl). 2013. PMID: 23860514 German.

3

[¹¹ C]Methionine emerges as a new biomarker for tracking active myeloma lesions.

Lapa C, Schreder M, Lückerath K, Samnick S, Rudelius M, Buck AK, Kortüm KM, Einsele H, Rosenwald A, Knop S. Lapa C, et al. Among authors: kortum km. Br J Haematol. 2018 Jun;181(5):701-703. doi: 10.1111/bjh.14696. Epub 2017 May 3. Br J Haematol. 2018. PMID: 28466502 Free article. Clinical Trial. No abstract available.

4

CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma.

Lapa C, Herrmann K, Schirbel A, Hänscheid H, Lückerath K, Schottelius M, Kircher M, Werner RA, Schreder M, Samnick S, Kropf S, Knop S, Buck AK, Einsele H, Wester HJ, Kortüm KM. Lapa C, et al. Among authors: kortum km. Theranostics. 2017 Apr 8;7(6):1589-1597. doi: 10.7150/thno.19050. eCollection 2017. Theranostics. 2017. PMID: 28529638 Free PMC article.

5

¹¹C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions.

Lapa C, Garcia-Velloso MJ, Lückerath K, Samnick S, Schreder M, Otero PR, Schmid JS, Herrmann K, Knop S, Buck AK, Einsele H, San-Miguel J, Kortüm KM. Lapa C, et al. Among authors: kortum km. Theranostics. 2017 Jul 23;7(11):2956-2964. doi: 10.7150/thno.20491. eCollection 2017. Theranostics. 2017. PMID: 28824728 Free PMC article.

6

First targeted therapy in multiple myeloma.

Kortüm KM, Einsele H. Kortüm KM, et al. Blood. 2017 Nov 30;130(22):2359-2360. doi: 10.1182/blood-2017-09-805341. Blood. 2017. PMID: 29191974 Free article. No abstract available.

7

Protocol for M³P: A Comprehensive and Clinical Oriented Targeted Sequencing Panel for Routine Molecular Analysis in Multiple Myeloma.

Barrio S, DáVia M, Bruins L, Stühmer T, Steinbrunn T, Bittrich M, Einsele H, Stewart AK, Braggio E, Kortüm KM. Barrio S, et al. Among authors: kortum km. Methods Mol Biol. 2018;1792:117-128. doi: 10.1007/978-1-4939-7865-6_8. Methods Mol Biol. 2018. PMID: 29797255

8

Spectrum and functional validation of PSMB5 mutations in multiple myeloma.

Barrio S, Stühmer T, Da-Viá M, Barrio-Garcia C, Lehners N, Besse A, Cuenca I, Garitano-Trojaola A, Fink S, Leich E, Chatterjee M, Driessen C, Martinez-Lopez J, Rosenwald A, Beckmann R, Bargou RC, Braggio E, Stewart AK, Raab MS, Einsele H, Kortüm KM. Barrio S, et al. Among authors: kortum km. Leukemia. 2019 Feb;33(2):447-456. doi: 10.1038/s41375-018-0216-8. Epub 2018 Jul 19. Leukemia. 2019. PMID: 30026573

9

Hexokinase-2 Expression in ¹¹C-Methionine-Positive, ¹⁸F-FDG-Negative Multiple Myeloma.

Kircher S, Stolzenburg A, Kortüm KM, Kircher M, Da Via M, Samnick S, Buck AK, Einsele H, Rosenwald A, Lapa C. Kircher S, et al. Among authors: kortum km. J Nucl Med. 2019 Mar;60(3):348-352. doi: 10.2967/jnumed.118.217539. Epub 2018 Nov 2. J Nucl Med. 2019. PMID: 30389821 Free article.

10

[Diagnostic and therapeutic considerations on recurrence of multiple myeloma : A current overview].

Kortüm KM, Einsele H. Kortüm KM, et al. Internist (Berl). 2019 Jan;60(1):34-41. doi: 10.1007/s00108-018-0528-9. Internist (Berl). 2019. PMID: 30536028 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page